ERBB2 and breast cancer: To develop spheroids representing hard-to-treat BC subtypes, namely TNBC and HER2+, we optimized preparation conditions using three cell lines (MDA-MB-231, BT-20, and BT-474 cells) selected for their importance in in vitro cancer research.